MAPT and early-onset autosomal dominant Alzheimer disease: We show that compounds such as bacopaside II, bacopaside XII, and nicotine showed optimal binding features with the R2 repeat domain of hyperphosphorylated tau protein forfurther consideration in the context of Alzheimer's disease (AD).